US8999957, Table 2, Compound 65

ID: ALA3654539

Chembl Id: CHEMBL3654539

PubChem CID: 89509127

Max Phase: Preclinical

Molecular Formula: C27H26FN5O2

Molecular Weight: 471.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CCCN(CC(=O)c5ccccc5F)C4)cc23)ccn1

Standard InChI:  InChI=1S/C27H26FN5O2/c1-17-13-18(10-11-29-17)26-22-14-19(8-9-24(22)31-32-26)27(35)30-20-5-4-12-33(15-20)16-25(34)21-6-2-3-7-23(21)28/h2-3,6-11,13-14,20H,4-5,12,15-16H2,1H3,(H,30,35)(H,31,32)/t20-/m1/s1

Standard InChI Key:  HNIMEUAPVHVSDP-HXUWFJFHSA-N

Associated Targets(non-human)

Mapk3 Mitogen-activated protein kinase 3 (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.54Molecular Weight (Monoisotopic): 471.2071AlogP: 4.15#Rotatable Bonds: 6
Polar Surface Area: 90.98Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.21CX Basic pKa: 5.25CX LogP: 3.18CX LogD: 3.17
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.41Np Likeness Score: -1.85

References

1.  (2015)  Heterocyclic compounds as ERK inhibitors, 

Source

Source(1):